Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Grogan

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Molecular Cancer Therapeutics|January 29, 2009
Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft linesMichelle J Clarke, Evan A Mulligan, Patrick T Grogan, et al.
Neuro-Oncology|March 13, 2013
Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft modelsLing Cen, Brett L Carlson, Jenny L Pokorny, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancerJann N Sarkaria, Paul Schwingler, Steven E Schild, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panelLin Yang, Michelle J Clarke, Brett L Carlson, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Molecular Cancer Therapeutics|January 29, 2009
Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft linesMichelle J Clarke, Evan A Mulligan, Patrick T Grogan, et al.
Neuro-Oncology|March 13, 2013
Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft modelsLing Cen, Brett L Carlson, Jenny L Pokorny, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancerJann N Sarkaria, Paul Schwingler, Steven E Schild, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panelLin Yang, Michelle J Clarke, Brett L Carlson, et al.
Pageof 6